## ADUS: Addus HomeCare Corporation - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 1.08 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-1.8% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($104.46)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Is Now the Time to Revisit Addus HomeCare After Recent Share Price Weakness?**
- Source: Simply Wall Street | 20251226T070828 | Somewhat-Bullish | Relevance: 100%
- Addus HomeCare (NASDAQ: ADUS) has experienced recent share price weakness, making investors question if it's a value opportunity. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 49.3%, while its Price-to-Earnings (PE) ratio makes it appear modestly expensive compared to its proprietary Fair Ratio. The article encourages investors to use "Narratives" to combine qualitative beliefs with quantitative assumptions for a tailored valuation.

**2. Harbor Capital Advisors Inc. Sells 42,163 Shares of Addus HomeCare Corporation $ADUS**
- Source: MarketBeat | 20251225T120946 | Neutral | Relevance: 100%
- Harbor Capital Advisors Inc. reduced its stake in Addus HomeCare Corporation by 62.7% during the third quarter, selling 42,163 shares and retaining 25,056 shares valued at approximately $2.96 million. Despite this, other institutional investors increased their positions, and Addus HomeCare recently reported strong Q3 earnings, beating analyst estimates with $1.56 EPS and $362.3 million in revenue. The company maintains a "Moderate Buy" consensus rating among analysts with an average price target of $137.11.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Blackrock Inc.: 14.8% (-1.1%)
- Vanguard Group Inc: 7.0% (+2.9%)
- Capital Research Glo: 6.5% (+9.0%)
- Wasatch Advisors LP: 5.1% (+0.8%)
- Silvercrest Asset Ma: 4.6% (+14.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.8% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.08 suggests fair value with growth premium. Balance sheet: low leverage (D/E 0.36). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.0B |
| Beta | 0.94 |
| 52W Range | $88.96 - $136.72 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.08 |
| Forward P/E | 16.1 |
| Current P/E | 17.9 |
| YoY Growth | 11.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -2.6% to -4.4% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.4pp (needs >4.0% for momentum thesis). AM_20 at -3.5% indicates price below own 20MA trend. Underperforming sector by 5.0pp, stock-specific weakness. Below SMA200 (1.00x), long-term trend not supportive. RSI neutral at 40. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.44% (CS: 11) | Weak |
| RSI_14 | 40.0 | Neutral |
| MACD Histogram | -0.42 | Bearish |
| vs SMA20 | 0.965x | Below |
| vs SMA50 | 0.955x | Below |
| vs SMA200 | 0.996x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $110.16
- **Stop Loss:** $104.46 (5.2% risk)
- **Target:** $121.56 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 231
- **Position Value:** $25,446.96
- **Portfolio %:** 25.45%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-23 (Est: $1.72)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.53 | $1.56 | +1.7% |
| 2025Q2 | $1.46 | $1.49 | +1.8% |
| 2025Q1 | $1.33 | $1.42 | +6.5% |
| 2024Q4 | $1.36 | $1.38 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*